Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 181154 |
| Drug Identification Number | 02439409 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL EPIDURAL |
| Packaging size | 10mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-01 |
| Estimated end date | 2023-04-01 |
| Actual end date | 2023-04-01 |
| Shortage status | Resolved |
| Updated date | 2023-04-04 |
| Company comments | Product is on 10% allocation from January 1, 2023 until January 31, 2023. Effective Feb. 1, 2023, allocations will be increased to cover 100% of 10 mL demand plus 100% of 20 mL demand at a 2:1 ratio. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-04-04 | French | Compare |
| v5 | 2023-04-04 | English | Compare |
| v4 | 2023-04-03 | French | Compare |
| v3 | 2023-04-03 | English | Compare |
| v2 | 2023-01-16 | French | Compare |
| v1 | 2023-01-16 | English | Compare |
Showing 1 to 6 of 6